Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation
2019 · Clinical Cancer Research · 106 citations
https://doi.org/10.1158/1078-0432.ccr-19-0353
N
Núria Moragas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
198
Citations
3
h-index
3
i10-index
Núria Moragas is an academic researcher from Bellvitge University Hospital. The author has contributed to research in topics: Fibroblast Growth Factor Research & Cancer Cells and Metastasis & Cancer, Hypoxia, and Metabolism. The author has an h-index of 3, co-authored 28 publications.
ORCID: 0009-0002-8863-3947Papers by this author
worksGlucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis
2018 · Breast Cancer Research · 29 citations
https://doi.org/10.1186/s13058-018-0977-z
The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma
2024 · Breast Cancer Research · 2 citations
https://doi.org/10.1186/s13058-024-01871-0
Additional file 8: of Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.6742697
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat